Connect with us

Psychedelics

Press Release: FILAMENT HEALTH ANNOUNCES SECOND PSILOCYBIN SUPPLY AGREEMENT WITH THE CENTRE FOR ADDICTION AND MENTAL HEALTH

Published

on


CAMH will study PEX010, Filament’s botanical psilocybin drug candidate, in a Health Canada-approved clinical trial for mild cognitive impairment

VANCOUVER, BC, Feb. 14, 2023 /CNW/ – Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (“Filament” or the “Company“), a clinical–stage natural psychedelic drug development company, today announced a second agreement to supply the Centre for Addiction and Mental Health (CAMH), Canada’s largest mental health teaching hospital and one of the world’s leading research centres, with the Company’s botanical psilocybin drug candidate, PEX010. CAMH will study the effects of psilocybin for the treatment of amnestic mild cognitive impairment (aMCI) in a Health Canada-approved clinical trial.

“Current treatments for aMCI are ineffective, and the examination of novel interventions is required to help prevent progression to Alzheimer’s Dementia (AD),”  said Dr. Philip Gerretsen, co-lead investigator for the CAMH trial. “This trial will examine if psilocybin can increase participants’ synaptic density, which has previously been shown to occur in animal studies. We are very grateful to Filament Health for their donation of safe, high quality psilocybin which is crucial to the trial design.”

Patients with aMCI are at higher risk of having Alzheimer’s Disease and developing dementia. No effective treatment currently exists to prevent progression from aMCI to AD, and psilocybin represents a novel approach to promote synaptogenesis in the early stages which may counter neurodegeneration.

“We’re proud to continue building our relationship with CAMH, one of the world’s most well-regarded mental health research institutions,” said Benjamin Lightburn, Chief Executive Officer and Co-Founder of Filament Health. “Supporting Dr. Gerretsen and Dr. Graff’s research by donating PEX010 advances Filament’s mission to see safe, natural psychedelics into the hands of everyone who needs them, as soon as possible.”

ABOUT FILAMENT HEALTH (OTCQB:FLHLF) (NEO:FH) (FSE:7QS)
Filament Health is a clinical-stage natural psychedelic drug development company. We believe that safe, standardized, naturally-derived psychedelic medicines can improve the lives of many, and our mission is to see them in the hands of everyone who needs them as soon as possible. Filament’s platform of proprietary intellectual property enables the discovery, development, and delivery of natural psychedelic medicines for clinical development. We are paving the way with the first-ever natural psychedelic drug candidates.



Source link

Continue Reading

Psychedelics

Alert: We are just over a week away from the Natural Medicine Division opening our application process to individuals who are interested in becoming business Owners or Natural Medicine Handlers, and to business applications for Healing Centers, Cultivations, Testing Facilities and Product Manufacturers.

Published

on

By


Dear Interested Parties:

 

We are just over a week away from the Natural Medicine Division opening our application process to individuals who are interested in becoming business Owners or Natural Medicine Handlers, and to business applications for Healing Centers, Cultivations, Testing Facilities and Product Manufacturers.

 

This week, we wanted to share some logistical information about the application process.

 

We encourage you to submit your application online, and there will be instructions on how to submit applications on the Natural Medicine Division website.

However, based on stakeholder feedback, we will be opening up limited appointment slots for in-person assistance at our Lakewood office starting on Friday, Jan. 10, 2025. At this time, Fridays will be the only day that we will be offering in-person natural medicine licensing application assistance. We will be open from 9 a.m. to noon and 1 p.m. to 4 p.m. for in-person Friday appointments.

We are finalizing the applications and will be sharing those prior to our application process coming online. You can always check out our Public Resources folder to find information and compliance tools.

As always, please reach out to us at [email protected].us if you have any questions.

 

Stay tuned!

The Natural Medicine Division



Source link

Continue Reading

Psychedelics

Mexican “Shamen” on The Run After Actress Dies In Frog Ceremony

Published

on

By


An actress in Mexico tragically lost her life after she ingested Amazonian frog venom as a part of a cleansing ritual while at a spiritual retreat. She experienced severe diarrhoea after taking part in the ceremony and was rushed to a hospital, but the doctors failed to save her life.

A shaman at the spiritual retreat where the actress took the Amazonian frog venom that caused her death has fled.
A shaman at the spiritual retreat where the actress took the Amazonian frog venom that caused her death has fled.

The 33-year-old actress Marcela Alcázar Rodríguez took part in the traditional South American Kambo ritual, which involves drinking water, getting burns on the body, and ingesting frog venom to cleanse the body of toxins, reported the Mirror. However, this ritual is known to have deadly consequences.

How is the Kambo ritual performed?

The participants in the ritual are made to drink more than a litre of water. Small burns are then created on their skin, following which frog mucus is applied on the wounds.

The mucus, which contains venom, increases blood pressure and induces vomiting, reported the outlet. It also causes diarrhoea in some cases. Other symptoms involve fainting, dizziness, swollen lips and face. Usually, the symptoms last for nearly half an hour. However, extended exposure of the venom to the blood stream can cause seizures and also death.

What happened to Marcela Alcázar Rodríguez?

Soon after beginning the ritual, Rodríguez reportedly started throwing up and eventually suffered from severe diarrhoea – these symptoms are often considered the body’s “healing” reactions during the cleansing process. Initially, she refused help but gave in when her friend visited her.

According to the Metro, a shaman at the retreat in Mayocoyani, Durango, told her she couldn’t leave. However, after her condition worsened, the person fled. Reportedly, police are now searching for the shaman.

Tribute to the actress

In a social media post, Durango Film Guild paid tribute to the actress after her untimely demise. They remembered her as “a young woman who worked in various short films, series and movies filmed in Durango.”

The guild added, “She leaves a void in the hearts of the people who knew her working in what she loved: cinema.”

 

https://www.hindustantimes.com/trending/actress-dies-after-taking-amazonian-frog-venom-during-cleansing-ritual-at-spiritual-retreat-101733371832107.html?ck_subscriber_id=1050193520



Source link

Continue Reading

Psychedelics

Dutch police find gnome made of MDMA during drug bust

Published

on

By


BBC

Officers in the southern Netherlands have found a garden gnome weighing nearly 2kg (4lb) and made of the drug MDMA.

“Drugs appear in many shapes and sizes, but every now and then we come across special things,” Dongemond Police said in a translated social media post.

The gnome was found among suspected narcotics during a large drug search.

“In itself a strange place to keep your garden gnome,” the force said. “That’s why we decided to test [it] for narcotics”.

“The gnome himself was visibly startled,” police said, referring to the gnome having its hands covering its mouth.

It is not known which area the gnome was recovered in, but the Dongemond Police covers the municipalities of Oosterhout, Geertruidenberg, Drimmelen and Altena.

MDMA – which is an illegal substance in the Netherlands – is a synthetic party drug also known as ecstasy.

As of 2019, the Netherlands was among the world’s leading producers of MDMA.



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media